2023/02/03
Coming Soon, The RSV Vaccines
Respiratory syncytial virus (RSV) is a significant contributor to infant mortality with limited prevention and treatment options. The fusion glycoprotein of RSV is thought as an ideal target for vaccine R&D, which exists in pre- and post-fusion forms. Due to their different performance in inducing n
더 보기
2023/01/06
An interview with CEO of ACROBiosystems, Mike Chen — Transforming Customer Journey
ACROBiosystems provides life sciences tools, reagents, and instruments,and aims to become the'cornerstone'of the pharma and biotech industry
더 보기
2022/11/16
ACROBiosystems Launches a new Logistics Center in Switzerland
ACROBiosystems launches its first European logistics center and warehouse in Basel, Switzerland.
더 보기
2023/02/04 - 2023/02/04
The 7th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum
Speaker: ACROBiosystems and others
Time: February 4, 2023
더 보기